Observational Study of Glycemic Control and Self-management of Young People (Aged 13 to 25 Years ) With Type 1 Diabetes During COVID-19 Lockdown.
Sponsor: Centre Hospitalier Sud Francilien
Trial Details
| Condition | Type 1 Diabetes |
| Intervention | glucose control and sensor usage |
| Status | Completed |
| Participants | 77 |
| Est. Completion | 22 Jan 2021 |
| Last Updated | 22 May 2026 |
Primary Outcome
Changes in percentage of time spent in range 70-180 mg/dL after lockdown compared to before lockdown; Changes in percentage of time spent in range 70-180 mg/dL during first month of lockdown compared to before lockdown; Changes in percentage of time spent in range 70-180 mg/dL during second month of lockdown compared to before lockdown
Eligibility Criteria
Inclusion Criteria
Inclusion Criteria: * Type 1 diabetes * Age between 13 and 25 years * use of a flash glucose monitoring related to the LibreView cloud platform * patients follow-up by the diabetes department of Hopital Sud Francilien or the diabetes department of Hôpital Bicêtre. * patient informed of the study and not having objected to it. Exclusion Criteria: * patients out of France during lockdown * other type of diabetes * Duration of diabetes of less than one year * patient aged under 13 years or above 26 years old
Trial Sites
Countries
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service